サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1785739

人工角膜インプラントの世界市場

Artificial Corneal Implants

出版日
ページ情報
英文 210 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.26円
人工角膜インプラントの世界市場
出版日: 2025年08月07日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 210 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

人工角膜インプラントの世界市場は2030年までに1億2,090万米ドルに達する見込み

2024年に8,280万米ドルと推定される人工角膜インプラントの世界市場は、2030年には1億2,090万米ドルに達し、分析期間2024-2030年のCAGRは6.5%で成長すると予測されます。本レポートで分析したセグメントの1つである硬質人工角膜は、CAGR 5.7％を記録し、分析期間終了時には6,570万米ドルに達すると予測されています。ソフト人工角膜セグメントの成長率は、分析期間中CAGR 7.5%と推定されます。

米国市場は2,180万米ドルと推定、中国はCAGR6.4％で成長予測

米国の人工角膜インプラント市場は、2024年に2,180万米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2024-2030年のCAGRを6.4%として、2030年には予測市場規模1,950万米ドルに達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ5.9％と5.6％と予測されています。欧州では、ドイツがCAGR 5.3%で成長すると予測されています。

世界の人工角膜インプラント市場- 主要動向と促進要因のまとめ

人工角膜インプラントはどのように視力低下に対応しているのか？

人工角膜インプラントは、角膜失明や角膜損傷の治療状況を一変させ、従来の角膜移植を受けられない患者に代替手段を提供しています。円錐角膜、角膜瘢痕、ジストロフィーなどの症状は、これらのインプラントを視力回復のための重要なソリューションにしています。生体適合性のある材料と手術技術の進歩により、これらのインプラントは統合性が向上し、拒絶反応のリスクが減少しています。角膜疾患の有病率の上昇とドナー角膜の世界の不足は、信頼性が高く利用しやすい選択肢として、人工インプラントの需要に拍車をかけています。

技術的進歩が治療成績向上に果たす役割とは？

人工角膜インプラント市場は、耐久性、生体適合性、手術のしやすさを向上させることに重点を置き、急速な技術革新を目の当たりにしています。ハイドロゲルやナノコンポジットのような先進的な材料は、天然の角膜の特性を模倣し、より優れた光学的透明性と合併症の減少を保証します。3Dプリンティング技術は、患者固有のインプラントを作成するために利用され、精度と治療成績を向上させています。低侵襲手術技術も登場し、回復にかかる時間を短縮し、資源の乏しい環境でも患者が利用しやすくなっています。このような技術的進歩により、人工角膜インプラントは現代眼科の礎石として位置付けられています。

なぜアクセシビリティが市場成長の鍵となるのか？

アクセシビリティは、特に角膜失明の負担が最も大きい発展途上国において、人工角膜インプラントの採用を促進する大きな要因です。非政府組織やヘルスケアシステムは、アクセシビリティのギャップを埋めるために、啓発キャンペーンや助成金付き治療に投資しています。さらに、費用対効果の高いインプラントオプションの出現により、十分なサービスを受けていない地域でも利用できるようになりました。メーカー、政府、ヘルスケアプロバイダー間のパートナーシップは、これらの人生を変える治療が最も必要としている人々に確実に届くようにしています。

人工角膜インプラント市場の成長の原動力は？

人工角膜インプラント市場の成長の原動力は、角膜疾患の有病率の増加とドナー角膜の世界の不足です。材料科学と3Dプリンティングの進歩により、耐久性が高く患者固有のインプラントの製造が可能になり、手術成績が向上しています。老年人口の増加とそれに伴う視力低下のリスクは、需要をさらに押し上げます。目の健康を促進する消費者の意識と政府の取り組みが、市場の裾野を広げています。さらに、低侵襲手術における技術的進歩により、角膜インプラントはより身近で手頃なものとなり、この分野の持続的成長を確実なものにしています。

セグメント

移植タイプ（硬質人工角膜、軟質人工角膜）、インプラントタイプ（合成インプラント、生体合成インプラント）、適応症（円錐角膜適応症、眼熱傷適応症、眼瘢痕性類天疱瘡（OCP）適応症、角膜間質ジストロフィー適応症、スティーブンス・ジョンソン症候群（SJS）適応症、その他の適応症）;エンドユーザー（病院エンドユーザー、眼科センターエンドユーザー、外来手術センターエンドユーザー）

調査対象企業の例

  • AJL Ophthalmic S.A.
  • Aurolab
  • Beijing mikpro medical device Co., Ltd.
  • CorneaGen
  • Corneat Vision Ltd.
  • DIOPTEX GmbH
  • EyeYon Medical Ltd.
  • FCI Ophthalmics, Inc.
  • Keramed Inc.
  • LinkoCare Life Sciences AB
  • Mediphacos
  • San Diego Eye Bank

AI統合

当社は、有効な専門家コンテンツとAIツールにより、市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家からキュレートされたコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP29231

Global Artificial Corneal Implants Market to Reach US$120.9 Million by 2030

The global market for Artificial Corneal Implants estimated at US$82.8 Million in the year 2024, is expected to reach US$120.9 Million by 2030, growing at a CAGR of 6.5% over the analysis period 2024-2030. Hard Keratoprosthesis, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$65.7 Million by the end of the analysis period. Growth in the Soft Keratoprosthesis segment is estimated at 7.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$21.8 Million While China is Forecast to Grow at 6.4% CAGR

The Artificial Corneal Implants market in the U.S. is estimated at US$21.8 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$19.5 Million by the year 2030 trailing a CAGR of 6.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 5.9% and 5.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.3% CAGR.

Global Artificial Corneal Implants Market - Key Trends & Drivers Summarized

How Are Artificial Corneal Implants Addressing Vision Loss?

Artificial corneal implants are transforming the treatment landscape for corneal blindness and damage, providing an alternative for patients who cannot undergo traditional corneal transplants. Conditions such as keratoconus, corneal scarring, and dystrophies have made these implants a critical solution for restoring vision. With advancements in biocompatible materials and surgical techniques, these implants offer improved integration and reduced risk of rejection. The rising prevalence of corneal diseases, coupled with a shortage of donor corneas globally, has fueled demand for artificial implants as a reliable and accessible option.

What Role Do Technological Advancements Play in Enhancing Outcomes?

The artificial corneal implant market is witnessing rapid innovation, with a focus on improving durability, biocompatibility, and surgical ease. Advanced materials such as hydrogels and nanocomposites mimic the natural cornea’s properties, ensuring better optical clarity and reduced complications. 3D printing technologies are being utilized to create patient-specific implants, enhancing precision and outcomes. Minimally invasive surgical techniques have also emerged, reducing recovery times and increasing accessibility for patients in low-resource settings. These technological strides have positioned artificial corneal implants as a cornerstone of modern ophthalmology.

Why Is Accessibility a Key Focus for Market Growth?

Accessibility is a major factor driving the adoption of artificial corneal implants, especially in developing countries where the burden of corneal blindness is highest. Non-governmental organizations and healthcare systems are investing in awareness campaigns and subsidized treatments to bridge the accessibility gap. Additionally, the emergence of cost-effective implant options has expanded availability in underserved regions. Partnerships between manufacturers, governments, and healthcare providers are ensuring that these life-changing treatments reach the people who need them most.

What Drives the Growth of the Artificial Corneal Implants Market?

The growth in the artificial corneal implants market is driven by an increasing prevalence of corneal diseases and a global shortage of donor corneas. Advancements in materials science and 3D printing have enabled the production of highly durable and patient-specific implants, improving surgical outcomes. The rise in geriatric populations and the associated risk of vision loss further boosts demand. Consumer awareness and government initiatives promoting eye health are expanding the market’s reach. Moreover, technological breakthroughs in minimally invasive procedures are making corneal implants more accessible and affordable, ensuring sustained growth in this sector.

SCOPE OF STUDY:

The report analyzes the Artificial Corneal Implants market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Transplant Type (Hard Keratoprosthesis, Soft Keratoprosthesis); Implant Type (Synthetic Implant, Biosynthetic Implant); Indication (Keratoconus Indication, Ocular Burns Indication, Ocular Cicatricial Pemphigoid (OCP) Indication, Corneal Stromal Dystrophies Indication, Stevens-Johnson Syndrome (SJS) Indication, Other Indications); End-Use (Hospitals End-Use, Ophthalmic Centers End-Use, Ambulatory Surgical Centers End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 44 Featured) -

  • AJL Ophthalmic S.A.
  • Aurolab
  • Beijing mikpro medical device Co., Ltd.
  • CorneaGen
  • Corneat Vision Ltd.
  • DIOPTEX GmbH
  • EyeYon Medical Ltd.
  • FCI Ophthalmics, Inc.
  • Keramed Inc.
  • LinkoCare Life Sciences AB
  • Mediphacos
  • San Diego Eye Bank

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Artificial Corneal Implants - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Corneal Blindness and Vision Disorders Driving Demand
    • Increasing Success Rates of Synthetic and Bioengineered Corneal Implants
    • Advancements in Stem Cell Therapy for Corneal Regeneration Supporting Growth
    • Growing Adoption of 3D Bioprinting Technology in Artificial Corneal Implants
    • Expansion of Minimally Invasive Corneal Implantation Techniques
    • Increasing Collaborations Between Ophthalmic Research Institutes and Manufacturers
    • Rising Geriatric Population Driving Demand for Vision Restoration Solutions
    • Advancements in Biocompatible and Long-Lasting Implant Materials
    • Expanding Access to Corneal Transplant Alternatives in Developing Countries
    • Growing Use of AI and Robotics in Corneal Implantation Surgeries
    • Surge in FDA and Regulatory Approvals for Next-Generation Implants
    • Rising Private and Government Investments in Ophthalmic Healthcare
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Artificial Corneal Implants Market Analysis of Annual Sales in US$ for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Artificial Corneal Implants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Artificial Corneal Implants by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Hard Keratoprosthesis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Hard Keratoprosthesis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Soft Keratoprosthesis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Soft Keratoprosthesis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Other Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Other Indications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Keratoconus Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Keratoconus Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Ocular Burns Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Ocular Burns Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Ocular Cicatricial Pemphigoid Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Ocular Cicatricial Pemphigoid Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Corneal Stromal Dystrophies Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Corneal Stromal Dystrophies Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Stevens-Johnson Syndrome Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 19: World 6-Year Perspective for Stevens-Johnson Syndrome Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 21: World 6-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Ophthalmic Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 23: World 6-Year Perspective for Ophthalmic Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 24: World Recent Past, Current & Future Analysis for Ambulatory Surgical Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 25: World 6-Year Perspective for Ambulatory Surgical Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Synthetic Implant by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 27: World 6-Year Perspective for Synthetic Implant by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Biosynthetic Implant by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 29: World 6-Year Perspective for Biosynthetic Implant by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Artificial Corneal Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 30: USA Recent Past, Current & Future Analysis for Artificial Corneal Implants by Transplant Type - Hard Keratoprosthesis and Soft Keratoprosthesis - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 31: USA 6-Year Perspective for Artificial Corneal Implants by Transplant Type - Percentage Breakdown of Value Sales for Hard Keratoprosthesis and Soft Keratoprosthesis for the Years 2025 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Artificial Corneal Implants by Indication - Other Indications, Keratoconus Indication, Ocular Burns Indication, Ocular Cicatricial Pemphigoid Indication, Corneal Stromal Dystrophies Indication and Stevens-Johnson Syndrome Indication - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA 6-Year Perspective for Artificial Corneal Implants by Indication - Percentage Breakdown of Value Sales for Other Indications, Keratoconus Indication, Ocular Burns Indication, Ocular Cicatricial Pemphigoid Indication, Corneal Stromal Dystrophies Indication and Stevens-Johnson Syndrome Indication for the Years 2025 & 2030
    • TABLE 34: USA Recent Past, Current & Future Analysis for Artificial Corneal Implants by End-Use - Hospitals End-Use, Ophthalmic Centers End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 35: USA 6-Year Perspective for Artificial Corneal Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ophthalmic Centers End-Use and Ambulatory Surgical Centers End-Use for the Years 2025 & 2030
    • TABLE 36: USA Recent Past, Current & Future Analysis for Artificial Corneal Implants by Implant Type - Synthetic Implant and Biosynthetic Implant - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 37: USA 6-Year Perspective for Artificial Corneal Implants by Implant Type - Percentage Breakdown of Value Sales for Synthetic Implant and Biosynthetic Implant for the Years 2025 & 2030
  • CANADA
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Artificial Corneal Implants by Transplant Type - Hard Keratoprosthesis and Soft Keratoprosthesis - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada 6-Year Perspective for Artificial Corneal Implants by Transplant Type - Percentage Breakdown of Value Sales for Hard Keratoprosthesis and Soft Keratoprosthesis for the Years 2025 & 2030
    • TABLE 40: Canada Recent Past, Current & Future Analysis for Artificial Corneal Implants by Indication - Other Indications, Keratoconus Indication, Ocular Burns Indication, Ocular Cicatricial Pemphigoid Indication, Corneal Stromal Dystrophies Indication and Stevens-Johnson Syndrome Indication - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 41: Canada 6-Year Perspective for Artificial Corneal Implants by Indication - Percentage Breakdown of Value Sales for Other Indications, Keratoconus Indication, Ocular Burns Indication, Ocular Cicatricial Pemphigoid Indication, Corneal Stromal Dystrophies Indication and Stevens-Johnson Syndrome Indication for the Years 2025 & 2030
    • TABLE 42: Canada Recent Past, Current & Future Analysis for Artificial Corneal Implants by End-Use - Hospitals End-Use, Ophthalmic Centers End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 43: Canada 6-Year Perspective for Artificial Corneal Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ophthalmic Centers End-Use and Ambulatory Surgical Centers End-Use for the Years 2025 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Artificial Corneal Implants by Implant Type - Synthetic Implant and Biosynthetic Implant - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada 6-Year Perspective for Artificial Corneal Implants by Implant Type - Percentage Breakdown of Value Sales for Synthetic Implant and Biosynthetic Implant for the Years 2025 & 2030
  • JAPAN
    • Artificial Corneal Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 46: Japan Recent Past, Current & Future Analysis for Artificial Corneal Implants by Transplant Type - Hard Keratoprosthesis and Soft Keratoprosthesis - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 47: Japan 6-Year Perspective for Artificial Corneal Implants by Transplant Type - Percentage Breakdown of Value Sales for Hard Keratoprosthesis and Soft Keratoprosthesis for the Years 2025 & 2030
    • TABLE 48: Japan Recent Past, Current & Future Analysis for Artificial Corneal Implants by Indication - Other Indications, Keratoconus Indication, Ocular Burns Indication, Ocular Cicatricial Pemphigoid Indication, Corneal Stromal Dystrophies Indication and Stevens-Johnson Syndrome Indication - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 49: Japan 6-Year Perspective for Artificial Corneal Implants by Indication - Percentage Breakdown of Value Sales for Other Indications, Keratoconus Indication, Ocular Burns Indication, Ocular Cicatricial Pemphigoid Indication, Corneal Stromal Dystrophies Indication and Stevens-Johnson Syndrome Indication for the Years 2025 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Artificial Corneal Implants by End-Use - Hospitals End-Use, Ophthalmic Centers End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan 6-Year Perspective for Artificial Corneal Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ophthalmic Centers End-Use and Ambulatory Surgical Centers End-Use for the Years 2025 & 2030
    • TABLE 52: Japan Recent Past, Current & Future Analysis for Artificial Corneal Implants by Implant Type - Synthetic Implant and Biosynthetic Implant - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 53: Japan 6-Year Perspective for Artificial Corneal Implants by Implant Type - Percentage Breakdown of Value Sales for Synthetic Implant and Biosynthetic Implant for the Years 2025 & 2030
  • CHINA
    • Artificial Corneal Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 54: China Recent Past, Current & Future Analysis for Artificial Corneal Implants by Transplant Type - Hard Keratoprosthesis and Soft Keratoprosthesis - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 55: China 6-Year Perspective for Artificial Corneal Implants by Transplant Type - Percentage Breakdown of Value Sales for Hard Keratoprosthesis and Soft Keratoprosthesis for the Years 2025 & 2030
    • TABLE 56: China Recent Past, Current & Future Analysis for Artificial Corneal Implants by Indication - Other Indications, Keratoconus Indication, Ocular Burns Indication, Ocular Cicatricial Pemphigoid Indication, Corneal Stromal Dystrophies Indication and Stevens-Johnson Syndrome Indication - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 57: China 6-Year Perspective for Artificial Corneal Implants by Indication - Percentage Breakdown of Value Sales for Other Indications, Keratoconus Indication, Ocular Burns Indication, Ocular Cicatricial Pemphigoid Indication, Corneal Stromal Dystrophies Indication and Stevens-Johnson Syndrome Indication for the Years 2025 & 2030
    • TABLE 58: China Recent Past, Current & Future Analysis for Artificial Corneal Implants by End-Use - Hospitals End-Use, Ophthalmic Centers End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 59: China 6-Year Perspective for Artificial Corneal Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ophthalmic Centers End-Use and Ambulatory Surgical Centers End-Use for the Years 2025 & 2030
    • TABLE 60: China Recent Past, Current & Future Analysis for Artificial Corneal Implants by Implant Type - Synthetic Implant and Biosynthetic Implant - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 61: China 6-Year Perspective for Artificial Corneal Implants by Implant Type - Percentage Breakdown of Value Sales for Synthetic Implant and Biosynthetic Implant for the Years 2025 & 2030
  • EUROPE
    • Artificial Corneal Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Artificial Corneal Implants by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 63: Europe 6-Year Perspective for Artificial Corneal Implants by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 64: Europe Recent Past, Current & Future Analysis for Artificial Corneal Implants by Transplant Type - Hard Keratoprosthesis and Soft Keratoprosthesis - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 65: Europe 6-Year Perspective for Artificial Corneal Implants by Transplant Type - Percentage Breakdown of Value Sales for Hard Keratoprosthesis and Soft Keratoprosthesis for the Years 2025 & 2030
    • TABLE 66: Europe Recent Past, Current & Future Analysis for Artificial Corneal Implants by Indication - Other Indications, Keratoconus Indication, Ocular Burns Indication, Ocular Cicatricial Pemphigoid Indication, Corneal Stromal Dystrophies Indication and Stevens-Johnson Syndrome Indication - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 67: Europe 6-Year Perspective for Artificial Corneal Implants by Indication - Percentage Breakdown of Value Sales for Other Indications, Keratoconus Indication, Ocular Burns Indication, Ocular Cicatricial Pemphigoid Indication, Corneal Stromal Dystrophies Indication and Stevens-Johnson Syndrome Indication for the Years 2025 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Artificial Corneal Implants by End-Use - Hospitals End-Use, Ophthalmic Centers End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Europe 6-Year Perspective for Artificial Corneal Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ophthalmic Centers End-Use and Ambulatory Surgical Centers End-Use for the Years 2025 & 2030
    • TABLE 70: Europe Recent Past, Current & Future Analysis for Artificial Corneal Implants by Implant Type - Synthetic Implant and Biosynthetic Implant - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 71: Europe 6-Year Perspective for Artificial Corneal Implants by Implant Type - Percentage Breakdown of Value Sales for Synthetic Implant and Biosynthetic Implant for the Years 2025 & 2030
  • FRANCE
    • Artificial Corneal Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 72: France Recent Past, Current & Future Analysis for Artificial Corneal Implants by Transplant Type - Hard Keratoprosthesis and Soft Keratoprosthesis - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 73: France 6-Year Perspective for Artificial Corneal Implants by Transplant Type - Percentage Breakdown of Value Sales for Hard Keratoprosthesis and Soft Keratoprosthesis for the Years 2025 & 2030
    • TABLE 74: France Recent Past, Current & Future Analysis for Artificial Corneal Implants by Indication - Other Indications, Keratoconus Indication, Ocular Burns Indication, Ocular Cicatricial Pemphigoid Indication, Corneal Stromal Dystrophies Indication and Stevens-Johnson Syndrome Indication - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 75: France 6-Year Perspective for Artificial Corneal Implants by Indication - Percentage Breakdown of Value Sales for Other Indications, Keratoconus Indication, Ocular Burns Indication, Ocular Cicatricial Pemphigoid Indication, Corneal Stromal Dystrophies Indication and Stevens-Johnson Syndrome Indication for the Years 2025 & 2030
    • TABLE 76: France Recent Past, Current & Future Analysis for Artificial Corneal Implants by End-Use - Hospitals End-Use, Ophthalmic Centers End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 77: France 6-Year Perspective for Artificial Corneal Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ophthalmic Centers End-Use and Ambulatory Surgical Centers End-Use for the Years 2025 & 2030
    • TABLE 78: France Recent Past, Current & Future Analysis for Artificial Corneal Implants by Implant Type - Synthetic Implant and Biosynthetic Implant - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 79: France 6-Year Perspective for Artificial Corneal Implants by Implant Type - Percentage Breakdown of Value Sales for Synthetic Implant and Biosynthetic Implant for the Years 2025 & 2030
  • GERMANY
    • Artificial Corneal Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 80: Germany Recent Past, Current & Future Analysis for Artificial Corneal Implants by Transplant Type - Hard Keratoprosthesis and Soft Keratoprosthesis - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Germany 6-Year Perspective for Artificial Corneal Implants by Transplant Type - Percentage Breakdown of Value Sales for Hard Keratoprosthesis and Soft Keratoprosthesis for the Years 2025 & 2030
    • TABLE 82: Germany Recent Past, Current & Future Analysis for Artificial Corneal Implants by Indication - Other Indications, Keratoconus Indication, Ocular Burns Indication, Ocular Cicatricial Pemphigoid Indication, Corneal Stromal Dystrophies Indication and Stevens-Johnson Syndrome Indication - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 83: Germany 6-Year Perspective for Artificial Corneal Implants by Indication - Percentage Breakdown of Value Sales for Other Indications, Keratoconus Indication, Ocular Burns Indication, Ocular Cicatricial Pemphigoid Indication, Corneal Stromal Dystrophies Indication and Stevens-Johnson Syndrome Indication for the Years 2025 & 2030
    • TABLE 84: Germany Recent Past, Current & Future Analysis for Artificial Corneal Implants by End-Use - Hospitals End-Use, Ophthalmic Centers End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 85: Germany 6-Year Perspective for Artificial Corneal Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ophthalmic Centers End-Use and Ambulatory Surgical Centers End-Use for the Years 2025 & 2030
    • TABLE 86: Germany Recent Past, Current & Future Analysis for Artificial Corneal Implants by Implant Type - Synthetic Implant and Biosynthetic Implant - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Germany 6-Year Perspective for Artificial Corneal Implants by Implant Type - Percentage Breakdown of Value Sales for Synthetic Implant and Biosynthetic Implant for the Years 2025 & 2030
  • ITALY
    • TABLE 88: Italy Recent Past, Current & Future Analysis for Artificial Corneal Implants by Transplant Type - Hard Keratoprosthesis and Soft Keratoprosthesis - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 89: Italy 6-Year Perspective for Artificial Corneal Implants by Transplant Type - Percentage Breakdown of Value Sales for Hard Keratoprosthesis and Soft Keratoprosthesis for the Years 2025 & 2030
    • TABLE 90: Italy Recent Past, Current & Future Analysis for Artificial Corneal Implants by Indication - Other Indications, Keratoconus Indication, Ocular Burns Indication, Ocular Cicatricial Pemphigoid Indication, Corneal Stromal Dystrophies Indication and Stevens-Johnson Syndrome Indication - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 91: Italy 6-Year Perspective for Artificial Corneal Implants by Indication - Percentage Breakdown of Value Sales for Other Indications, Keratoconus Indication, Ocular Burns Indication, Ocular Cicatricial Pemphigoid Indication, Corneal Stromal Dystrophies Indication and Stevens-Johnson Syndrome Indication for the Years 2025 & 2030
    • TABLE 92: Italy Recent Past, Current & Future Analysis for Artificial Corneal Implants by End-Use - Hospitals End-Use, Ophthalmic Centers End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Italy 6-Year Perspective for Artificial Corneal Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ophthalmic Centers End-Use and Ambulatory Surgical Centers End-Use for the Years 2025 & 2030
    • TABLE 94: Italy Recent Past, Current & Future Analysis for Artificial Corneal Implants by Implant Type - Synthetic Implant and Biosynthetic Implant - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 95: Italy 6-Year Perspective for Artificial Corneal Implants by Implant Type - Percentage Breakdown of Value Sales for Synthetic Implant and Biosynthetic Implant for the Years 2025 & 2030
  • UNITED KINGDOM
    • Artificial Corneal Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 96: UK Recent Past, Current & Future Analysis for Artificial Corneal Implants by Transplant Type - Hard Keratoprosthesis and Soft Keratoprosthesis - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 97: UK 6-Year Perspective for Artificial Corneal Implants by Transplant Type - Percentage Breakdown of Value Sales for Hard Keratoprosthesis and Soft Keratoprosthesis for the Years 2025 & 2030
    • TABLE 98: UK Recent Past, Current & Future Analysis for Artificial Corneal Implants by Indication - Other Indications, Keratoconus Indication, Ocular Burns Indication, Ocular Cicatricial Pemphigoid Indication, Corneal Stromal Dystrophies Indication and Stevens-Johnson Syndrome Indication - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 99: UK 6-Year Perspective for Artificial Corneal Implants by Indication - Percentage Breakdown of Value Sales for Other Indications, Keratoconus Indication, Ocular Burns Indication, Ocular Cicatricial Pemphigoid Indication, Corneal Stromal Dystrophies Indication and Stevens-Johnson Syndrome Indication for the Years 2025 & 2030
    • TABLE 100: UK Recent Past, Current & Future Analysis for Artificial Corneal Implants by End-Use - Hospitals End-Use, Ophthalmic Centers End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 101: UK 6-Year Perspective for Artificial Corneal Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ophthalmic Centers End-Use and Ambulatory Surgical Centers End-Use for the Years 2025 & 2030
    • TABLE 102: UK Recent Past, Current & Future Analysis for Artificial Corneal Implants by Implant Type - Synthetic Implant and Biosynthetic Implant - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 103: UK 6-Year Perspective for Artificial Corneal Implants by Implant Type - Percentage Breakdown of Value Sales for Synthetic Implant and Biosynthetic Implant for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 104: Rest of Europe Recent Past, Current & Future Analysis for Artificial Corneal Implants by Transplant Type - Hard Keratoprosthesis and Soft Keratoprosthesis - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Rest of Europe 6-Year Perspective for Artificial Corneal Implants by Transplant Type - Percentage Breakdown of Value Sales for Hard Keratoprosthesis and Soft Keratoprosthesis for the Years 2025 & 2030
    • TABLE 106: Rest of Europe Recent Past, Current & Future Analysis for Artificial Corneal Implants by Indication - Other Indications, Keratoconus Indication, Ocular Burns Indication, Ocular Cicatricial Pemphigoid Indication, Corneal Stromal Dystrophies Indication and Stevens-Johnson Syndrome Indication - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 107: Rest of Europe 6-Year Perspective for Artificial Corneal Implants by Indication - Percentage Breakdown of Value Sales for Other Indications, Keratoconus Indication, Ocular Burns Indication, Ocular Cicatricial Pemphigoid Indication, Corneal Stromal Dystrophies Indication and Stevens-Johnson Syndrome Indication for the Years 2025 & 2030
    • TABLE 108: Rest of Europe Recent Past, Current & Future Analysis for Artificial Corneal Implants by End-Use - Hospitals End-Use, Ophthalmic Centers End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 109: Rest of Europe 6-Year Perspective for Artificial Corneal Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ophthalmic Centers End-Use and Ambulatory Surgical Centers End-Use for the Years 2025 & 2030
    • TABLE 110: Rest of Europe Recent Past, Current & Future Analysis for Artificial Corneal Implants by Implant Type - Synthetic Implant and Biosynthetic Implant - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Rest of Europe 6-Year Perspective for Artificial Corneal Implants by Implant Type - Percentage Breakdown of Value Sales for Synthetic Implant and Biosynthetic Implant for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Artificial Corneal Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 112: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Corneal Implants by Transplant Type - Hard Keratoprosthesis and Soft Keratoprosthesis - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 113: Asia-Pacific 6-Year Perspective for Artificial Corneal Implants by Transplant Type - Percentage Breakdown of Value Sales for Hard Keratoprosthesis and Soft Keratoprosthesis for the Years 2025 & 2030
    • TABLE 114: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Corneal Implants by Indication - Other Indications, Keratoconus Indication, Ocular Burns Indication, Ocular Cicatricial Pemphigoid Indication, Corneal Stromal Dystrophies Indication and Stevens-Johnson Syndrome Indication - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 115: Asia-Pacific 6-Year Perspective for Artificial Corneal Implants by Indication - Percentage Breakdown of Value Sales for Other Indications, Keratoconus Indication, Ocular Burns Indication, Ocular Cicatricial Pemphigoid Indication, Corneal Stromal Dystrophies Indication and Stevens-Johnson Syndrome Indication for the Years 2025 & 2030
    • TABLE 116: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Corneal Implants by End-Use - Hospitals End-Use, Ophthalmic Centers End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Asia-Pacific 6-Year Perspective for Artificial Corneal Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ophthalmic Centers End-Use and Ambulatory Surgical Centers End-Use for the Years 2025 & 2030
    • TABLE 118: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Corneal Implants by Implant Type - Synthetic Implant and Biosynthetic Implant - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 119: Asia-Pacific 6-Year Perspective for Artificial Corneal Implants by Implant Type - Percentage Breakdown of Value Sales for Synthetic Implant and Biosynthetic Implant for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 120: Rest of World Recent Past, Current & Future Analysis for Artificial Corneal Implants by Transplant Type - Hard Keratoprosthesis and Soft Keratoprosthesis - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 121: Rest of World 6-Year Perspective for Artificial Corneal Implants by Transplant Type - Percentage Breakdown of Value Sales for Hard Keratoprosthesis and Soft Keratoprosthesis for the Years 2025 & 2030
    • TABLE 122: Rest of World Recent Past, Current & Future Analysis for Artificial Corneal Implants by Indication - Other Indications, Keratoconus Indication, Ocular Burns Indication, Ocular Cicatricial Pemphigoid Indication, Corneal Stromal Dystrophies Indication and Stevens-Johnson Syndrome Indication - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Rest of World 6-Year Perspective for Artificial Corneal Implants by Indication - Percentage Breakdown of Value Sales for Other Indications, Keratoconus Indication, Ocular Burns Indication, Ocular Cicatricial Pemphigoid Indication, Corneal Stromal Dystrophies Indication and Stevens-Johnson Syndrome Indication for the Years 2025 & 2030
    • TABLE 124: Rest of World Recent Past, Current & Future Analysis for Artificial Corneal Implants by End-Use - Hospitals End-Use, Ophthalmic Centers End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 125: Rest of World 6-Year Perspective for Artificial Corneal Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ophthalmic Centers End-Use and Ambulatory Surgical Centers End-Use for the Years 2025 & 2030
    • TABLE 126: Rest of World Recent Past, Current & Future Analysis for Artificial Corneal Implants by Implant Type - Synthetic Implant and Biosynthetic Implant - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 127: Rest of World 6-Year Perspective for Artificial Corneal Implants by Implant Type - Percentage Breakdown of Value Sales for Synthetic Implant and Biosynthetic Implant for the Years 2025 & 2030

IV. COMPETITION